Literature DB >> 25753327

United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings.

Hasan Rizvi1, Tom Butler, Mariarita Calaminici, Indraraj U Doobaree, Raghava C Nandigam, Dimitri Bennett, Drew Provan, Adrian C Newland.   

Abstract

Fibrosis has been reported in some patients with immune thrombocytopenia (ITP) treated with thrombopoietin receptor agonists (TPO-RA). However, fibrosis has also been reported in patients with various stages of ITP, who were TPO-RA treatment-naïve. In our study, we looked for fibrosis in bone marrow trephine biopsies taken at initial diagnosis from 32 adult patients with ITP. Ten of the 32 evaluated samples (31·25%) showed increased reticulin (Grade 1-2 on Bauermeister scale and Grade 0-1 on the European Consensus scale), which showed a positive correlation with ethnicity (0·3%) but did not correlate with disease severity, any clinical features or co-morbidities.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  bone marrow fibrosis; co-morbidities; collagen fibrosis; primary immune thrombocytopenia; reticulin fibrosis

Mesh:

Substances:

Year:  2015        PMID: 25753327     DOI: 10.1111/bjh.13330

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2017-01-25       Impact factor: 3.443

2.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

3.  Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel.

Authors:  Nichola Cooper; Quentin A Hill; John Grainger; John-Paul Westwood; Charlotte Bradbury; Drew Provan; Jecko Thachil; Nicholas Ramscar; Anuja Roy
Journal:  Acta Haematol       Date:  2021-03-31       Impact factor: 2.195

4.  Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry.

Authors:  Donald M Arnold; Ishac Nazy; Rumi Clare; Anushka M Jaffer; Brandon Aubie; Na Li; John G Kelton
Journal:  Blood Adv       Date:  2017-11-28

5.  Primary autoimmune myelofibrosis with severe thrombocytopenia mimicking immune thrombocytopenia: A case report.

Authors:  Jian Hua; Shu Matayoshi; Tomoyuki Uchida; Morihiro Inoue; Masao Hagihara
Journal:  Mol Clin Oncol       Date:  2016-10-26

6.  Thrombopoietin Receptor Agonists Are Often Ineffective in Immune Thrombocytopenia and/or Cause Adverse Reactions: Results from One Hand.

Authors:  Fabian Depré; Nasra Aboud; Frauke Ringel; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2016-07-18       Impact factor: 3.747

Review 7.  The role of extracellular matrix stiffness in megakaryocyte and platelet development and function.

Authors:  Orly Leiva; Catherine Leon; Seng Kah Ng; Pierre Mangin; Christian Gachet; Katya Ravid
Journal:  Am J Hematol       Date:  2018-01-12       Impact factor: 10.047

8.  Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.

Authors:  Indraraj Umesh Doobaree; Adrian Newland; Vickie McDonald; Raghava Nandigam; Lesley Mensah; Sandrine Leroy; Anouchka Seesaghur; Hitan Patel; Sally Wetten; Drew Provan
Journal:  Eur J Haematol       Date:  2019-03-07       Impact factor: 2.997

9.  Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim.

Authors:  Christian Fynbo Christiansen; Shahram Bahmanyar; Waleed Ghanima; Nickolaj Risbo; Charlotta Ekstrand; Scott Stryker; John Acquavella; Karynsa Kilpatrick; Henrik Frederiksen; Mette Nørgaard; Henrik Toft Sørensen
Journal:  EClinicalMedicine       Date:  2019-08-23

10.  Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia.

Authors:  Ann Janssens; Francesco Rodeghiero; David Anderson; Beng H Chong; Zoltán Boda; Ingrid Pabinger; Libor Červinek; Deirdra R Terrell; Xuena Wang; Janet Franklin
Journal:  Ann Hematol       Date:  2016-04-30       Impact factor: 3.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.